According to
GuruFocus Insider Data
, these are the largest CFO buys during the past week. The
overall trend of CFOs is illustrated in the chart below:
ZBB Energy Corporation (
ZBB
): CFO William C. Hogoboom Bought 28,947 Shares
CFO of ZBB Energy Corporation (
ZBB
) William C. Hogoboom bought 28,947 shares on 06/14/2012 at an
average price of $0.38. ZBB Energy Corporation develops and
manufactures distributed energy storage solutions based on the
Company's proprietary zinc-bromine rechargeable electrical energy
storage technology. ZBB Energy Corporation has a market cap of
$16.2 million; its shares were traded at around $0.35 with and
P/S ratio of 9.
ZBB Energy Corporation reported revenues of $1,645,291 and
$3,724,069 for the three and nine months ended March 31, 2012,
respectively, representing increases of $1,439,320 and
$3,283,417, or 699% and 745%, compared to the corresponding
fiscal 2011 periods. Net loss on the basis of accounting
principles generally accepted in the United States (GAAP) was
$3.47 million or $0.09 per share and $7.88 million or $0.23 per
share in the three and nine months ended March 31, 2012,
respectively, compared to $2.9 million and $6.7 million, or $0.12
and $0.33 per share in the three and nine months ended March 31,
2011, respectively.
CEO and President
Eric C. Apfelbach
, CFO
William C. Hogoboom
, and Executive Vice President Operations
Charles W. Stankiewicz
bought shares of ZBB stock.
PharMerica Corporation (
PMC
): Executive Vice President and CFO Michael J. Culotta Bought
15,000 Shares
Executive Vice President and CFO of PharMerica Corporation (
PMC
) Michael J. Culotta bought 15,000 shares on 06/14/2012 at an
average price of $9.51. PharMerica Corporation is an
institutional pharmacy services provider dedicated to providing
quality customer service and innovative pharmacy solutions to
institutional customers and patients in long-term care settings.
PharMerica Corporation has a market cap of $300.3 million; its
shares were traded at around $10.71 with a P/E ratio of 7.7 and
P/S ratio of 0.1. PharMerica Corporation had an annual average
earnings growth of 18.6% over the past 5 years.
PharMerica Corporation reported its financial results for the
first quarter of 2012. Net income for the first quarter of 2012
was $5.6 million, or $0.19 per diluted common share, compared
with $3.3 million, or $0.11 per diluted common share, for the
same period in 2011. Revenues for the first quarter of 2012 were
$498.9 million compared with $535.1 million for the first quarter
of 2011, a decrease of 6.8%, primarily driven by weaker volumes
and increased dispensing of high margin generics.
CEO Gregory S. Weishar, Executive Vice President and CFO Michael
J. Culotta, and Executive Vice President William E. Monast bought
shares of PMC stock.
For the complete list of stocks that bought by their CFOs, go to:
Insider Buys.About GuruFocus: GuruFocus.com tracks the stocks
picks and portfolio holdings of the world's best investors. This
value investing site offers stock screeners and valuation tools.
And publishes daily articles tracking the latest moves of the
world's best investors. GuruFocus also provides promising stock
ideas in 3 monthly newsletters sent to
Premium Members
.